Group One Trading’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-111
Closed -$12.2K 8202
2023
Q3
$12.2K Hold
111
﹤0.01% 6234
2023
Q2
$16.1K Hold
111
﹤0.01% 6125
2023
Q1
$15.7K Hold
111
﹤0.01% 5671
2022
Q4
$16.5K Buy
+111
New +$20.2K ﹤0.01% 5720
2021
Q2
Sell
-2
Closed -$998 8587
2021
Q1
$1K Sell
2
-30
-94% -$21.6K ﹤0.01% 7480
2020
Q4
$18K Buy
32
+4
+14% +$1.99K ﹤0.01% 5576
2020
Q3
$9K Buy
+28
New +$9.72K ﹤0.01% 5469
2017
Q2
Sell
-1
Closed -$1K 5092
2017
Q1
$1K Hold
1
﹤0.01% 4519
2016
Q4
$1K Hold
1
﹤0.01% 4326
2016
Q3
$1K Hold
1
﹤0.01% 4455
2016
Q2
$1K Hold
1
﹤0.01% 4524
2016
Q1
$1K Buy
+1
New +$1.59K ﹤0.01% 4457
2015
Q3
Sell
-15
Closed -$41K 5200
2015
Q2
$41K Buy
+15
New +$39K ﹤0.01% 3662
2014
Q4
Sell
-53
Closed -$137K 5277
2014
Q3
$145K Buy
53
+13
+33% +$42.2K ﹤0.01% 2664
2014
Q2
$138K Buy
+40
New +$142K ﹤0.01% 2709
2014
Q1
Sell
-306
Closed -$1.2M 5585
2013
Q4
$1.15M Buy
306
+104
+51% +$374K 0.02% 1002
2013
Q3
$658K Buy
202
+84
+71% +$246K 0.01% 1371
2013
Q2
$297K Buy
+118
New +$294K 0.01% 1800

Other funds holding TRIB

Group One Trading's TRIB Position: Q4 2023 in Review

Group One Trading sold out of Trinity Biotech (TRIB) in Q4 2023, closing a stake of 111 shares — an estimated $12.2K sold.

Group One Trading first reported a position in TRIB in Q2 2013 and held it in 18 quarters. The position peaked at $1.15M in Q4 2013. 24 funds tracked by Wall St. Rank hold TRIB as of Q4 2023.

  • Group One Trading reported no remaining Trinity Biotech position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 111 Trinity Biotech shares in Q4 2023, an estimated $12.2K.
  • Group One Trading first reported a position in Trinity Biotech in Q2 2013 and held it in 18 quarters.
  • Group One Trading's Trinity Biotech position peaked at $1.15M in Q4 2013.
  • 24 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.